Abstract
Drug-induced vasculitis can rarely cause inflammation and necrosis of blood vessel walls of both kidney and lung tissue. Diagnosis is challenging because of the lack of difference between systemic and drug-induced vasculitis in clinical presentation, immunological workup and pathological findings. Tissue biopsy guides diagnosis and treatment. Pathological findings must be correlated with clinical information to arrive at a presumed diagnosis of drug-induced vasculitis. We present a patient with hydralazine-induced antineutrophil cytoplasmic antibodies-positive vasculitis with a pulmonary-renal syndrome manifesting as pauci-immune glomerulonephritis and alveolar haemorrhage.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 27-31 |
| Number of pages | 5 |
| Journal | Drug and Therapeutics Bulletin |
| Volume | 63 |
| Issue number | 2 |
| DOIs | |
| State | Published - Jan 27 2025 |
Keywords
- drugs and medicines
- renal system
ASJC Scopus subject areas
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Diagnostic dilemma: drug-induced vasculitis versus systemic vasculitis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS